EU MDR establishes requirements for the safety, performance, and marketing of medical devices to ensure patient safety. The EU MDR medical device classification system has been developed to simplify the regulatory pathway for medical devices entering Europe. Correct classification is the foundation of the EU MDR regulatory strategy. It determines the conformity assessment route, clinical evidence requirements, Notified Body involvement, and post-market obligations.
What is EU MDR?
European Union Medical Device Regulation (EU MDR) is the regulatory framework governing the safety, performance, and marketing of medical devices in the European Union. It replaced the former Medical Device Directive (MDD). EU MDR introduced stricter requirements for clinical evidence, risk management, post-market surveillance, traceability, and quality management systems. The regulation applies to manufacturers, importers, distributors, and authorized representatives. EU MDR ensures that medical devices placed on the EU market are safe, effective, and compliant throughout their lifecycle. Furthermore, it also establishes risk-based device classification rules, Unique Device Identification (UDI) requirements, and increased oversight by Notified Bodies. Hence, it enhances patient safety and transparency across the European medical device industry.
What is EU MDR medical device classification system?
EU MDR medical device classification system is the risk-based system defined under the European Union Medical Device Regulation. It categorizes medical devices into four classes according to their intended purpose, level of risk, invasiveness, duration of use, and impact on patient safety. This classification determines the regulatory requirements applicable to the device, including conformity assessment procedures, clinical evidence expectations, Notified Body involvement, and post-market surveillance obligations before the device can be CE marked and placed on the EU market.
7 Key factors used for EU MDR medical device classification
- Intended medical purpose: The intended purpose is the primary factor used to classify a medical device under EU MDR. Manufacturers must clearly define how the device is intended to be used, who will use it, and the medical condition it addresses.
- Duration of use: Devices are classified based on how long they remain in continuous use with a patient. EU MDR categorizes duration as transient use (less than 60 minutes), short-term use (up to 30 days), or long-term use (more than 30 days).
- Degree of invasiveness: The classification considers whether the device enters the body and the extent of body penetration. Generally, more invasive devices are assigned to higher risk classes due to increased potential for harm.
- Implantability: Devices intended to be fully or partially implanted in the body usually receive a higher classification. This is because implantation can involve greater risks and long-term effects on patient health.
- Active or non-active nature: Active devices require an external energy source, such as electricity or software-driven functionality, to operate. These devices are often subject to stricter classification rules because malfunction could directly impact patient safety.
- Contact with: Devices that contact the heart, major blood vessels, brain, or spinal cord are generally classified in higher risk categories. Any failure or malfunction in these areas can lead to serious injury or death.
- Potential risk to patients and users: The overall level of risk associated with the device significantly influences its classification. Devices with a higher likelihood of causing harm or serious health consequences are assigned to higher classes. Hence, they require greater regulatory scrutiny.
EU MDR medical device classes
EU MDR categorizes medical devices into four classes, namely Class I, Class IIa, Class IIb, or Class III. The EU MDR medical device classification system is based on the device’s intended purpose, level of risk, invasiveness, duration of use, and impact on patient safety.
Class I (low risk devices)
Class I devices present the lowest level of risk to patients and users. These devices typically have simple designs and are intended for non-invasive or low-risk applications. Manufacturers can generally self-certify compliance with EU MDR requirements. However, some Class I devices with measuring or sterile functions require Notified Body involvement. Examples: Bandages, wheelchairs, examination gloves, and non-sterile surgical instruments.
Class IIa (low to medium risk devices)
Class IIa devices pose a moderate level of risk and typically support diagnosis, monitoring, or treatment activities. These devices require assessment by a Notified Body before they can be CE marked and marketed in the EU. Manufacturers must demonstrate safety, performance, and compliance through technical documentation and clinical evidence. Examples: Hearing aids, ultrasound equipment, dental filling materials, and diagnostic imaging software.
Class IIb (medium to high-risk devices)
Class IIb devices present a higher level of risk because they often administer treatment, sustain life, or interact more closely with the body. These devices are subject to more rigorous conformity assessment procedures and greater regulatory scrutiny. Manufacturers must provide extensive clinical and technical evidence to support device safety and effectiveness. Examples: Ventilators, infusion pumps, orthopedic implants, and long-term surgically invasive devices.
Class III (highest risk devices)
Class III devices carry the highest level of risk and are often life-supporting, life-sustaining, or implanted in critical parts of the body. These devices require the most stringent conformity assessment process, including comprehensive clinical evaluation and Notified Body review. The potential consequences of device failure are significant, thereby making robust safety and performance data essential. Examples: Pacemakers, heart valves, coronary stents, implantable defibrillators, and certain implantable neurological devices.
Special consideration for SaMD under EU MDR
Software as a Medical Device (SaMD) is primarily classified under Rule 11 of the EU MDR medical device classification rules. This rule evaluates the software based on the significance of the information it provides and the potential impact on patient health if the software produces incorrect results.
Software that provides information used to make diagnostic or therapeutic decisions may be classified as Class IIa, IIb, or III, depending on the severity of the medical situation. If an incorrect decision could lead to death or irreversible deterioration of health, the software is typically classified as Class III.
Software intended for monitoring physiological processes is generally classified as Class IIa. However, it may be classified as Class IIb when monitoring vital parameters where variations could pose an immediate danger to the patient. Examples include software that monitors cardiac rhythm, oxygen saturation, or other critical physiological functions.
Notably, many software products that were previously classified as Class I under the Medical Device Directive (MDD) were up-classified under EU MDR Rule 11. Examples: Clinical decision support software, diagnostic imaging analysis software, AI-based radiology software, etc.
Class-wise EU MDR requirements
- Class I devices: Class I devices are subject to the least stringent regulatory requirements under EU MDR because they present the lowest level of risk. Manufacturers must establish technical documentation, implement post-market surveillance activities, and issue an EU Declaration of Conformity before applying the CE mark.
- Class IIa devices: Class IIa devices require assessment by a Notified Body to verify compliance with applicable EU MDR requirements. Manufacturers must provide technical documentation, clinical evaluation evidence, and a quality management system appropriate to the device’s risk level.
- Class IIb devices: Class IIb devices are subject to a more rigorous conformity assessment due to their higher risk profile. Manufacturers must provide comprehensive clinical evidence, undergo detailed Notified Body review, and maintain robust post-market surveillance and vigilance processes.
- Class III devices: Class III devices face the most stringent regulatory requirements under EU MDR because they present the highest potential risk to patients. Manufacturers must submit extensive clinical evidence, undergo in-depth Notified Body assessment, and, where applicable, obtain expert panel review before CE marking.
Notably, all device classes must comply with the General Safety and Performance Requirements (GSPRs).
In this blog, we have summarised EU MDR medical device classification system. For any assistance with CE marking and compliance with EU MDR guidelines, drop an email at [email protected] or call/Whatsapp on 9996859227.
